Medicare, under Part A, pays a hospice a lump sum for each day a patient is receiving care at the facility. That money is supposed to cover any medications used to ease pain or help someone’s terminal illness.
However, Part D was also paying for some of these prescription drugs, the report found.
In 2016, the OIG estimates that Part D paid $160.8 million for drugs that should have been paid for under the Medicare Part A hospice benefit.
“CMS must do more to avoid paying twice for the same drugs. As we have previously recommended, CMS should work directly with hospices to ensure that they are providing drugs covered under the hospice benefit,” the OIG recommended.
More articles on pharmacy:
FDA approves AbbVie’s $59K rheumatoid arthritis drug
Teva launches generic version of EpiPen for kids
American Regent boosted price of essential hospital product by 1,300%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
